Synapse

← Surgical Oncology Insight

Papers in Surgical Oncology Insight

Page 3 · newest first

  1. Risk factors for early versus late venous thromboembolism after cytoreductive surgery and HIPECSurgical Oncology Insight · 2024
  2. Analysis of 3144 case reports in the gastrointestinal stromal tumor literature: Identification of underappreciated demographics, clinical presentations, and biologySurgical Oncology Insight · 2024
  3. Utility of tumor-informed circulating tumor DNA for detection of minimal residual disease after curative-intent therapy in localized pancreatic cancerSurgical Oncology Insight · 2024
  4. Outcomes of minimally invasive and open prophylactic gastrectomy for hereditary diffuse gastric cancerSurgical Oncology Insight · 2024
  5. Impact of an online risk prediction tool for sentinel node metastasis on clinical decision-making in melanoma care: A mixed methods studySurgical Oncology Insight · 2024
  6. Effect of travel distance on outcomes of patients with malignant peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical Oncology Insight · 2024
  7. Outcomes of mediastinal envelope closure during minimally invasive esophagectomySurgical Oncology Insight · 2024
  8. Real-world analysis of neuroendocrine tumor misdiagnosis and associated costsSurgical Oncology Insight · 2024
  9. Variability in treatment approaches, outcomes, and recurrence patterns after curative intent treatment for primary retroperitoneal sarcomas in Latin America: A report on 333 patients from LATAMSARC collaborative working groupSurgical Oncology Insight · 2024
  10. Is pancreatic adenosquamous carcinoma (PASC) a surgical disease? A large healthcare system reviewSurgical Oncology Insight · 2024
  11. Systemic inflammatory markers: Predictors of survival in mucinous appendix cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical Oncology Insight · 2024
  12. Combining liver-directed and immunotherapy in advanced hepatocellular carcinoma: A review and future directionsSurgical Oncology Insight · 2024
  13. Immunotherapy in gastroesophageal adenocarcinoma: What is the state of management?Surgical Oncology Insight · 2024
  14. Pelvic Floor Physical Therapy Prehabilitation (PrePFPT) for the prevention of low anterior resection syndromeSurgical Oncology Insight · 2024
  15. How reliable are post-mastectomy breast reconstruction videos on YouTube?Surgical Oncology Insight · 2024
  16. Adjuvant breast radiation therapy practice patterns in the United States from 2012–2017Surgical Oncology Insight · 2024
  17. DNA mismatch repair deficiency as a biomarker in sarcomaSurgical Oncology Insight · 2024
  18. Laparoscopic versus robotic pancreaticoduodenectomy: A NSQIP analysis comparing trends in patient selection and outcomes over 5-yearsSurgical Oncology Insight · 2024
  19. Nerve graft reconstruction of irradiated oncologic segmental nerve defects in the extremities: A case seriesSurgical Oncology Insight · 2024
  20. Is it time to de-escalate axillary surgery in patients with ductal carcinoma in-situ undergoing mastectomy?Surgical Oncology Insight · 2024
  21. The evolution of breast ultrasound in surgical practice: Current applications, missed opportunities, and future directionsSurgical Oncology Insight · 2024
  22. Pepsinogen and Helicobacter pylori: Serum biomarkers for gastric cancer risk in a diverse United States populationSurgical Oncology Insight · 2024
  23. Anxiety and Depression are Common in Surgical Oncology Patients: Results of a Prospective Cohort StudySurgical Oncology Insight · 2024
  24. Association between warfarin and survival in invasive melanoma: a population-based cohort studySurgical Oncology Insight · 2024
  25. Understanding the cancer health literacy gap: NCCN member institutions’ website readability across the high mortality cancers in the USSurgical Oncology Insight · 2024
  26. Minimum number of lymph nodes to maximize survival in non-metastatic appendiceal adenocarcinomaSurgical Oncology Insight · 2024
  27. Strategies for reoperative parathyroidectomySurgical Oncology Insight · 2024
  28. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) vs. Postoperative Intraperitoneal (IP) Chemotherapy - Impact on Health-Related Quality of Life in Primary Ovarian Cancer Patients after Cytoreductive SurgerySurgical Oncology Insight · 2024
  29. Evolving patterns of metastatic spread, treatment, and outcome for patients with oligometastatic colorectal cancerSurgical Oncology Insight · 2024
  30. Risk factors of a positive resection margin in locoregional appendix cancer and its impact on survival: The national cancer database analysisSurgical Oncology Insight · 2024
  31. Travel distance does not affect overall survival in patients with appendiceal adenocarcinoma undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical Oncology Insight · 2024
  32. Disaggregating U.S. Asian and Pacific Islanders: Colorectal cancerSurgical Oncology Insight · 2024
  33. Interference with activities of daily living according to pain level after breast surgerySurgical Oncology Insight · 2024
  34. Incidence and survival of Extramammary Paget’s Disease from the Surveillance, Epidemiology, and End Results (SEER) databaseSurgical Oncology Insight · 2024
  35. The impact of a bloodless medicine program on pancreatic resections: A single-institution experience incorporating patients with borderline-resectable and locally advanced pancreatic cancerSurgical Oncology Insight · 2024
  36. Minimally invasive training in surgical oncology: Current status and needs assessmentSurgical Oncology Insight · 2024
  37. Expanding the use of nipple sparing mastectomy: A review of the indications and techniquesSurgical Oncology Insight · 2024
  38. Clinicopathological features and short-term surgical outcomes of early-onset versus late-onset colorectal cancer at a tertiary hospital in Tanzania: A retrospective-cohort studySurgical Oncology Insight · 2024
  39. The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomesSurgical Oncology Insight · 2024
  40. Enhancing the National Cancer Database content using natural language processing and electronic health record dataSurgical Oncology Insight · 2024
  41. Role of locoregional therapy in gastric cancer with peritoneal metastasisSurgical Oncology Insight · 2024
  42. Safety and margin positivity rates of surgeon-performed intraoperative ultrasound-guided wire localization for breast cancerSurgical Oncology Insight · 2024
  43. Trends in incidence of oral cavity squamous cell carcinoma in the United States 2001-2019Surgical Oncology Insight · 2024
  44. Trends in socioeconomic inequalities in pancreatic cancer mortality in Canada: Evidence from the Canadian Vital Statistics Death DatabaseSurgical Oncology Insight · 2024
  45. Transhiatal esophagectomy after major thoracic surgery. Don’t give up too soon!Surgical Oncology Insight · 2024
  46. Contemporary trends in breast cancer in females under the age of fifty: An NCDB studySurgical Oncology Insight · 2024
  47. Phase I dose escalation study for In Vivo Lung Perfusion (IVLP) as an adjuvant treatment for patients with resectable pulmonary metastasis of bone or soft tissue sarcomasSurgical Oncology Insight · 2024
  48. Implementation of the 2015 American Thyroid Association guideline changes across a health system: A quality improvement opportunitySurgical Oncology Insight · 2024
  49. Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocolSurgical Oncology Insight · 2024
  50. Malignant bowel obstruction: Historical lessons, current trends, and future directionsSurgical Oncology Insight · 2024